mTOR kinase activity has been previously found to be up-regulated in PCa cells in response to androgens [35], and the mTOR pathway is important in clinical PCa, particularly in tumours lacking expression of PTEN (phosphatase and tensin homolog). Here, PTEN is linked to neoplasm.